查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433458

全球支架技术市场 2023-2030

Global Scaffold Technology Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期（2023-2030年），全球支架技术市场将以10.2%的复合CAGR成长。全球对器官移植、重建手术的需求不断增长，以及基于 3D 基底的 3D 矩阵设计的研发活动的增加，正在促进市场成长。细胞间交互作用、高通量扫描、转染和细胞迁移测定等 3D 培养测定均使用支架技术。此外，血管化和器官植入再生等组织培养应用于损伤和患病器官或组织的治疗，也将进一步为支架技术的发展提供潜在机会。

细分市场前景

全球支架技术市场按类型、疾病类型、应用和最终用户细分。根据类型，市场细分为水凝胶、聚合物支架、微图案表面微孔板和奈米纤维支架。根据疾病类型，市场细分为骨科、肌肉骨骼和脊椎、癌症、皮肤和外皮、牙科等。根据应用，市场细分为干细胞治疗、再生医学和组织工程以及药物开发。此外，根据最终用户，市场细分为生物技术和製药组织、研究实验室和研究所以及医院和诊断中心。在该类型中，由于水凝胶微加工製程的技术进步预计将在预测期内加速该细分市场的成长，因此预计水凝胶细分市场将占据相当大的市场份额。该公司正在推出用于细胞移植、药物储存和再狭窄屏障的新型水凝胶。例如，2021 年3 月，Bio-Techne Corporation 宣布推出Cultrex UltiMatrix 减少生长因子基底膜萃取物(RGF BME)，这是一种细胞外基质水凝胶，可为培养类器官和多能干细胞提供显着的性能和一致性优势。

干细胞治疗、再生医学和组织工程细分市场预计将在全球支架技术市场中占据相当大的份额

其中，干细胞治疗、再生医学和组织工程以及药物开发细分领域预计将在全球支架技术市场中占据相当大的份额。支架技术在重建手术、美容手术、腹壁修復、牙周病学、软组织肿瘤修復和大肠直肠治疗的应用越来越频繁。根据国际美容整形外科协会 (ISAPS) 的数据，2021 年整形外科医生实施的手术总体增长了 19.3%，全球范围内实施的手术数量超过 1,280 万例，非手术手术数量超过 1,750 万例。移植血液干细胞是最知名且最常使用的干细胞治疗方法。它可用于治疗免疫系统和血液系统疾病，以及在某些癌症治疗后修復血液系统。在欧洲，每年约有 26,000 名患者使用血液干细胞进行治疗。

此外，研究人员对支架技术在再生医学领域的广泛使用越来越感兴趣。例如，2020 年 11 月，维克森林再生医学研究所 (WFIRM) 的科学家推出了一种可用于软骨再生的混合组织结构。它是利用 3D 生物列印技术创建的。因此，组织发育研究的不断扩展可归因于节段扩展。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Thermo Fisher Scientific Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Becton, Dickinson and Company
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Merck Group
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球支架技术市场
    • 水凝胶
    • 聚合物支架
    • 微图案表面微孔板
    • 奈米纤维支架
  • 按疾病类型分類的全球支架技术市场
    • 骨科、肌肉骨骼和脊柱
    • 癌症
    • 皮肤和外皮
    • 牙科
    • 其他（心臟病学和血管学、神经学和泌尿学）
  • 全球支架技术市场（按应用）
    • 干细胞治疗、再生医学、组织工程
    • 药物开发
  • 按最终用户分類的全球支架技术市场
    • 生物技术与製药组织
    • 研究实验室和研究所
    • 医院和诊断中心

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
  • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 3D Biotek, LLC
  • AbbVie Inc.
  • Akron Biotech
  • Avacta Life Sciences Ltd.
  • Avantor, Inc.
  • BICO Group
  • Corning Inc.
  • India Medtronic Pvt Ltd.
  • Lonza Group Ltd.
  • Molecular Matrix, Inc.
  • Nanofiber Solutions, LLC
  • NuVasive, Inc.
  • PELOBIOTECH GmbH
  • REPROCELL
  • Vericel Corp.
Product Code: OMR2028046

Global Scaffold technology Market Size, Share & Trends Analysis Report by Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds),by Disease Type (Orthopedics, Musculoskeletal, & Spine, Cancer, Skin & Integumentary, Dental and Others),by Application (Stem Cell Therapy, Regenerative Medicine,& Tissue Engineering, and Drug Development) and by End-User (Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers)Forecast Period (2023-2030)

The global scaffold technology market is anticipated to grow at a considerable CAGR of 10.2% during the forecast period (2023-2030). The rising demand for organ transplant, reconstruction procedures globally and increase in R&D initiatives on the design of a 3D matrix that is based on 3D substrates is enabling the market growth. 3D culture assays such as cell to cell interactions, high throughput scanning, transfections, and cell migration assays all use scaffold technology. In addition, the tissue culture such as vascularization and organ implant regeneration applied in the treatment of damaged and diseased organs or tissues will further provide potential opportunities for the growth of the scaffold technology

Segmental Outlook

The global scaffold technology market is segmented by the type, disease type, application, and end-user. Based on the type, the market is sub-segmented into hydrogels, polymeric scaffolds, micropatterned surface microplates and nanofiber-based scaffolds. Based on disease type the market is sub-segmented into orthopedics, musculoskeletal, & spine, cancer, skin & integumentary, dental and others. Based on the application, the market is sub-segmented into stem cell therapy, regenerative medicine& tissue engineering, and drug development. Further, based on the end-user, the market is sub-segmented into biotechnology & pharmaceutical organizations, research laboratories & institutes, and hospitals & diagnostic centers. Among the type, the hydrogels sub-segment is anticipated to hold a considerable share of the market owing to technological advancements in microfabrication procedures for hydrogels are anticipated to accelerate the segment growth during the forecast period. Companies are launching new hydrogels for cell transplantation, drug depots, and a barrier against restenosis. For instance, in March, 2021 Bio-Techne Corporation announced the release of Cultrex UltiMatrix Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel that provides significant performance and consistency benefits for culturing organoids and pluripotent stem cells.

Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Sub-Segment is Anticipated to Hold a Considerable Share of the Global Scaffold technology Market

Among the application, the stem cell therapy, regenerative medicine & tissue engineering, and drug development sub-segment is expected to hold a considerable share of the global scaffold technology market. Scaffold technology is being utilized increasingly frequently in reconstructive surgeries, aesthetic surgeries, abdominal wall repair, periodontology, soft tissue tumor repair and colorectal treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS), a 19.3% overall increase in procedures performed by plastic surgeons in 2021 with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed globally. Transplanting blood stem cells is the most well-known and often used stem cell treatment. It may be used to treat immune system and blood system disorders, as well as to repair the blood system following treatment for certain cancers. Blood stem cells are used to treat around 26,000 patients annually in Europe.

Furthermore, researchers have become increasingly interested in the widespread use of scaffold technologies in the field of regenerative medicine. For instance, in November 2020, Wake Forest Institute for Regenerative Medicine (WFIRM) scientists, introduced a hybrid tissue structure that can be used for cartilage regeneration. It was created with the use of 3D bioprinting technology. As a result, the expanding research into tissue development can be ascribed to segment expansion.

Regional Outlook

The global scaffold technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The growing presence of government organizations that conduct regenerative medicine and stem cell research is a key factor driving the regional market growth. India has a vibrant stem cell research ecosystem, with both private and government institutions contributing to the field. For instance, in 2021 financial assistance for stem cell research activities is being provided by the Indian Government. The Government of India has undertaken stem cell research through various Departments/ Institutions, including the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST). Additionally, increasing public consciousness about the use of organ transplants and increased expenditures in healthcare infrastructure in countries such as India and China also contribute to the regional market's expansion.

North America Expected to Hold Considerable Share in the Global Scaffold technology Market

in the high incidences of cancer, increase in number of organ transplantation, and expansion of biotechnology & pharmaceutical companies is a key factor driving demand for scaffold technology. Growing R&D across the region is further contributing regional market share. For instance, in April 2023, Systemic Bio opened its new lab in Texas, US for hydrogel scaffold manufacturing and research and development activities for organ-on-a-chip technology to enhance drug discovery and development. Disease such as cancer has a major impact in the US. Cancer surgery is a common part of diagnosing and treating cancer. Surgery can show the size of the cancer and whether it has spread, which helps to figure out the cancer's stage. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the US. The most common cancers were breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, and non-Hodgkin lymphoma. Additionally due to presence of major companies including Akron Biotech, 3D Biotek LLC, Thermo Fisher Scientific Inc., Molecular Matrix Inc., Xanofi, and Corning Incorporated is propelling the region's growth.

Market Players Outlook

The major companies serving the scaffold technology market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza Group Ltd., 3D Biotek, LLC, Molecular Matrix, Inc., PELOBIOTECH GmbH, India Medtronic Pvt Ltd., Avacta Life Sciences Ltd., AbbVie, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, were working together to commercialize innovative 3D-printed scaffolds for bone regeneration. The bone scaffolds are made with Evonik's Resomer polymers and are used for large and complex bone defects. Both companies initially began collaborating in 2019 on scaffolds for chest wall and breast reconstruction.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global scaffold technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Thermo Fisher Scientific Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton, Dickinson and Company
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Merck Group
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Scaffold Technology Market by Type
    • 4.1.1. Hydrogels
    • 4.1.2. Polymeric Scaffolds
    • 4.1.3. Micropatterned Surface Microplates
    • 4.1.4. Nanofiber Based Scaffolds
  • 4.2. Global Scaffold Technology Market by Disease Type
    • 4.2.1. Orthopedics, Musculoskeletal, & Spine
    • 4.2.2. Cancer
    • 4.2.3. Skin & Integumentary
    • 4.2.4. Dental
    • 4.2.5. Others (Cardiology & Vascular, Neurology and Urology)
  • 4.3. Global Scaffold Technology Market by Application
    • 4.3.1. Stem Cell Therapy, Regenerative Medicine, Tissue Engineering
    • 4.3.2. Drug Development
  • 4.4. Global Scaffold Technology Market by End-User
    • 4.4.1. Biotechnology & Pharmaceutical Organizations
    • 4.4.2. Research Laboratories & Institutes
    • 4.4.3. Hospitals & Diagnostic Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
  • 5.4. Rest of Asia-Pacific
  • 5.5. Rest of the World

6. Company Profiles

  • 6.1. 3D Biotek, LLC
  • 6.2. AbbVie Inc.
  • 6.3. Akron Biotech
  • 6.4. Avacta Life Sciences Ltd.
  • 6.5. Avantor, Inc.
  • 6.6. BICO Group
  • 6.7. Corning Inc.
  • 6.8. India Medtronic Pvt Ltd.
  • 6.9. Lonza Group Ltd.
  • 6.10. Molecular Matrix, Inc.
  • 6.11. Nanofiber Solutions, LLC
  • 6.12. NuVasive, Inc.
  • 6.13. PELOBIOTECH GmbH
  • 6.14. REPROCELL
  • 6.15. Vericel Corp.

LIST OF TABLES

  • 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL HYDROGELSSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL POLYMERIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MICROPATTERNEDSURFACE MICROPLATESSCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NANOFIBER BASED SCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 7. GLOBAL SCAFFOLD TECHNOLOGY FOR ORTHOPEDICS, MUSCULOSKELETAL, & SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SCAFFOLD TECHNOLOGY FOR CANCERMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SCAFFOLD TECHNOLOGY FOR SKIN & INTEGUMENTARY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SCAFFOLD TECHNOLOGY FOR DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL SCAFFOLD TECHNOLOGY FOR OTHER DISEASEMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SCAFFOLD TECHNOLOGY FOR STEM CELL THERAPY, REGENERATIVE MEDICINE, AND TISSUE ENGINEERINGMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SCAFFOLD TECHNOLOGY FOR DRUG DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 16. GLOBAL SCAFFOLD TECHNOLOGY FOR BIOTECHNOLOGY & PHARMACEUTICAL ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL SCAFFOLD TECHNOLOGY FOR RESEARCH LABORATORIES & INSTITUTESMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL SCAFFOLD TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC CENTERSMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 25. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 28. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 29. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 30. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 34. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL HYDROGELSSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL POLYMERICSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MICROPATTERNED SURFACE MICROPLATESSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 5. GLOBAL NANOFIBER BASEDSCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022 VS 2030 (%)
  • 7. GLOBAL SCAFFOLD TECHNOLOGY FOR ORTHOPEDICS, MUSCULOSKELETAL, & SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SCAFFOLD TECHNOLOGY FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SCAFFOLD TECHNOLOGY FOR SKIN & INTEGUMENTARY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SCAFFOLD TECHNOLOGY FOR DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SCAFFOLD TECHNOLOGY FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 13. GLOBAL SCAFFOLD TECHNOLOGY FOR STEM CELL THERAPY, REGENERATIVE MEDICINE, TISSUE ENGINEERINGMARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SCAFFOLD TECHNOLOGY FOR DRUG DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022 VS 2030 (%)
  • 16. GLOBAL SCAFFOLD TECHNOLOGY FOR BIOTECHNOLOGY & PHARMACEUTICAL ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL SCAFFOLD TECHNOLOGY FORRESEARCH LABORATORIES & INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL SCAFFOLD TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 20. US SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CANADA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. UK SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. FRANCE SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. GERMANY SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. ITALY SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SPAIN SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. INDIA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. CHINA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. JAPAN SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. SOUTH KOREA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. REST OF THEWORLD SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)